Le Lézard
Classified in: Health, Science and technology
Subject: AWD

3M Acclaimed by Frost & Sullivan for the 3Mtm 360 Encompasstm System, Its AI-driven Technology for Healthcare Coding and Documentation


The 3Mtm 360 Encompasstm System seamlessly integrates CAC, CDI, concurrent quality metrics, and analytics to capture, analyze, and advance patient information across the continuum of care

SANTA CLARA, Calif., Dec. 6, 2018 /CNW/ -- Based on its recent analysis of the North American clinical documentation improvement (CDI) market, Frost & Sullivan recognizes 3M Health Information Systems with the 2018 North American Technology Leadership Award for its industry-leading 3Mtm 360 Encompasstm System. It was one of the first computer-assisted coding (CAC) products in the market and the first to combine coding, CDI, and quality metrics into a single unified platform. It leverages artificial intelligence (AI), natural language processing (NLP), statistics, and rules to comb through disparate data and information in a patient's medical record to automate coding and improve documentation.

2018 North American Clinical Documentation Improvement Technology Leadership Award

"3M 360 Encompass, with its new computer-assisted features like annotation of documents and auto-suggested codes, emerged the ideal solution for healthcare providers to manage the challenges and complexities of ICD-10," said Principal Healthcare Analyst Nancy Fabozzi. "Its NLP platform locates important information that may have been overlooked, identifies missing information, and then auto-suggests a physician query, all while the patient is still in the hospital."

3M's solution has more documents coming into the system for its CAC mechanism when compared to any comparable solution, and this enables its AI tool to learn and grow faster. It interfaces seamlessly with leading inpatient electronic health record (EHR) systems like Epic®, Cerner®, and Allscripts® to support a variety of additional functions such as utilization review, case management, and physician documentation. As a further value addition, it integrates with leading ambulatory EHRs, and the company's consulting services team handles outsourced coding, CDI, and other health information management (HIM) operations for both outpatient services and ambulatory practices.

The 3Mtm 360 Encompasstm System consists of five core functionalities?computer-assisted facility coding, hierarchical condition category (HCC) management, computer-assisted CDI, computer-assisted physician documentation, and computer-assisted professional coding. These features and functions allow providers to match in-patient data with diagnosis codes, which can result in early warning indicators and ultimately, superior patient care. The platform also offers computer-assisted physician documentation (CAPD), which generates smart, prioritized, and intelligent alerts to enhance clinician interaction with EHRs.

"Significantly, the solution's automation of time-intensive and resource-heavy coding tasks optimizes the CDI workflow and human resource allocation, allowing providers to achieve their business goals in the most cost-effective manner," noted Fabozzi "3M's foresight and commitment to innovation has enabled it to consistently deliver CDI tools that help healthcare providers improve care delivery as well as financial and operational efficiencies."

Each year, Frost & Sullivan presents the Technology Leadership Award to the company that has demonstrated uniqueness in developing and leveraging new technologies that deliver significant customer value.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About 3M

3M applies science in collaborative ways to improve lives daily. With $30 billion in sales, the company's 90,000 employees connect with customers all around the world. Learn more about 3M's creative solutions to the world's problems at www.3M.com or on Twitter @3M or @3MNewsroom.

Contact:

Mollie Houns
Price Houns Associates
952-920-6951

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector, and the investment community. Contact us: Start the discussion.

Contact:

Claudia Toscano
P: 210.477.8417
F: 210.348.1003
E: [email protected]

 

SOURCE Frost & Sullivan


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: